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Abstract
Respiratory syncytial virus (RSV) nonstructural protein 1(NS1) attenuates type-I interferon (IFN) production during RSV
infection; however the precise role of RSV NS1 protein in orchestrating the early host-virus interaction during infection is
poorly understood. Since NS1 constitutes the first RSV gene transcribed and the production of IFN depends upon RLR (RIG-I-
like receptor) signaling, we reasoned that NS1 may interfere with this signaling. Herein, we report that NS1 is localized to
mitochondria and binds to mitochondrial antiviral signaling protein (MAVS). Live-cell imaging of rgRSV-infected A549
human epithelial cells showed that RSV replication and transcription occurs in proximity to mitochondria. NS1 localization
to mitochondria was directly visualized by confocal microscopy using a cell-permeable chemical probe for His6-NS1. Further,
NS1 colocalization with MAVS in A549 cells infected with RSV was shown by confocal laser microscopy and immuno-
electron microscopy. NS1 protein is present in the mitochondrial fraction and co-immunoprecipitates with MAVS in total cell
lysatesof A549 cells transfected with the plasmid pNS1-Flag. By immunoprecipitation with anti-RIG-I antibody, RSV NS1 was
shown to associate with MAVS at an early stage of RSV infection, and to disrupt MAVS interaction with RIG-I (retinoic acid
inducible gene) and the downstream IFN antiviral and inflammatory response. Together, these results demonstrate that NS1
binds to MAVS and that this binding inhibits the MAVS-RIG-I interaction required for IFN production.
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Introduction
Respiratory syncytial virus (RSV) is a leading etiological agent
of lower respiratory tract infections in young children and
immunocompromised individuals [1,2,3]. RSV infection causes
an estimated 64 million cases of respiratory disease and 166,000
deaths annually worldwide and RSV-induced bronchiolitis and
pneumonia result in over 2000 deaths and 100,000 hospitaliza-
tions annually in the USA [4]. RSV infections recur throughout
life since immunity to natural RSV infections fails to generate
protective memory responses [5]. No effective vaccine or drug is
currently available. Previous efforts to generate a vaccine to RSV
using formalin-inactivated virus led to enhanced respiratory
disease and the deaths of two vaccinated children after later
RSV infection [6,7]. Subsequently, it was found that formalin-
RSV vaccination failed to adequately stimulate receptors of innate
immunity, such as Toll-like receptors (TLRs) [8]. New approaches
for RSV antivirals involve specifically targeting the RSV proteins
that enhance infection and viral survival through RNA interfer-
ence with the nucleocapsid [9,10,11] and nonstructural protein 1
(NS1) [12,13,14,15]. Human RSV is a poor inducer of the type-1
IFN response and infection leads to epithelial damage and ac-
tivation of inflammatory cytokine signaling. RSV employs multiple
defenses against the innate and adaptive antiviral response
through impairment of IFN production and interference with
lymphocyte activation [16,17,18]. RSV nonstructural genes NS1
and NS2, located in the 39 region of the negative-sense RNA viral
genome and transcribed first, are important players early after
infection in RSV’s subversion of the host antiviral response
[12,19,20,21,22,23]. We have shown that NS1 plays a very
important role in down-regulating IFN production and decreasing
activation of IFN-related signaling pathways [12,13]. However,
the precise mechanism remains unknown.
Recently, NS2 was shown to bind to RIG-I but not to MAVS,
and was involved in downstream signaling for IFN production
[23]. Given the differences in NS1 and NS2 expression and
function, we reasoned that investigation of the subcellular
localization and interactions of NS1 might shed light on its role
in subversion of the innate immune response to RSV infection.
Because of a potential role of NS1 in apoptosis [24], we specifically
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e29386examined the association of NS1 with the mitochondria and
mitochondrial antiviral signaling protein (MAVS). We have
demonstrated the localization of NS1 to the proximity of
mitochondria and the binding of NS1 to MAVS on mitochondria
using three microscopy approaches. Our results show that RSV
NS1 is associated with mitochondrial MAVS during infection, thus
inhibiting MAVS-RIG-I interaction which might indirectly affect
IFN production.
Materials and Methods
Cell culture
Human embryonic lung fibroblast HEp-2 (CCL-23) cells,
human alveolar epithelial A549 (CCL-185) cells and African
green monkey kidney Vero (CCL-81) cells were all purchased from
the American Type Culture Collection (ATCC) and were cultured
in standard Dulbecco’s MEM (DMEM) containing 5% heat-
inactivated fetal bovine serum, L-glutamine, 100 IU/ml penicillin
and 100 mg/ml streptomycin sulfate.
Viruses
Recombinant RSV strains rA2, rA2DNS1, rA2DNS2 and rA2-
His6-NS1 have been previously described [25]. RgRSV, which
expresses green fluorescent protein, was a gift from Dr. Mark
Peeples. Viruses rA2-His6-NS1 and rA2 RSV were grown in HEp-
2 cells and harvested when cytopathic effects became visible (2–3
days). RSV-infected cells were subjected to a single round of
freeze-thaw cycles and viral supernatant was clarified by
centrifugation at 3200 rpmat 4uC for 10 min. Viral titers were
obtained through plaque assay with 0.8% methylcellulose overlay
and immunostaining with monoclonal murine anti-RSV F anti-
body, followed by a horseradish peroxidase-conjugated secondary
antibody and visualization with 4CN substrate (Kirkegaard and
Perry Laboratories). The deletion mutant rA2DNS1 was cultured
in Vero cells and viral titer was also determined in the same cells.
For microscopy studies, A549 and HEp-2 cells were seeded to sub-
confluency on glass-bottom culture dishes 24 hrs before infection.
On the day of infection, growth media was replaced with Opti-
MEM (Invitrogen) containing the appropriate amount of virus
suspension for obtaining the indicated multiplicity of infection
(MOI).
Confocal microscopy
A549 cells were infected with rgRSV and imaged from the start
of infection for 16 h using a Nikon T inverted microscope running
the Perkin Elmer UltraVIEWHVoX 3D Live Cell Imaging System.
In a different experiment, A549 cells were infected with rA2 or
rA2DNS1 and 24 h later the cells were stained with the Image-iT
Live Mitochondrial and Nuclear Labeling Kit (Molecular Probes,
Invitrogen), using the mitochondrial stain CMXRos, according to
the manufacturer’s protocol. Cells were fixed with 4% parafor-
maldehyde, permeabilized with cold 0.2% Triton X-100 in PBS
for 10 min, washed twice with PBS and incubated with primary
rabbit IgG antibody conjugated to ZenonAlexa Fluor (Invitrogen).
Alexa 488 was conjugated to anti-His6-NS1antibody and Alexa
647 was conjugated to anti-MAVS antibody (Bethyl Laboratories).
Stained cells were viewed under a Leica TCS SP2 laser scanning
confocal microscope.
Fluorescent imaging of histidine-tagged protein using
cell permeable Ni
2+NTA-BM dye in live cells
HEp-2 cells were seeded in 35 mm glass-bottom confocal culture
dishesandinfectedwithrA2-His6-NS1atanMOIof2for10 h.Ni
2+-
NTA2-dibromobimane (Ni
2+-NTA2-BM) was prepared as previously
d e s c r i b e d[ 2 6 , 2 7 ]a n du s e dt ol a b e lr A 2 - H i s 6-NS1-infected live
HEp-2 cells 10 hrs post-infection. 50 mMN T A 2-BM was complexed
with a 10-fold molar excess of NiSO4 a n di n c u b a t e dw i t ha m m o n i u m
bicarbonate buffer-washed RSV-infected cells, together with a
mitochondrial labeling probe, CMXRos and nuclear (DRAQ5, Cell
Signaling) stain, following manufacturers’ instructions. Infection with
rA2 was used as a control to test target specificity. Fluorescence was
visualized by laser confocal microscopy at wavelengths of 405, 563
and 633 nm. Cells were also photographed using differential
interference contrast (DIC). A series of 0.5 mm Z-stack images was
collected of each specimen and experiments were performed in
triplicate. Semi-quantitative analysis with the JACoP provided
Pearson’s and Manders’ overlap coefficients (http://rsb.info.nih.
gov/ij/plugins/track/jacop.html).
Immunogold electron microscopy
A549 cells were grown to near confluence in T-75 flasks (USA
Scientific), infected with 0.5 MOI of rA2-His6-NS1 and harvested
at 12 and 24 h post-infection. The cells were pelleted and fixed in
1% paraformaldehyde, 0.5% glutaraldehyde, 0.05% sodium
cacodylate, pH 7.1, for 10 min at 4uC, then in 2% paraformal-
dehyde, 2.5% glutaraldehyde, 0.05% sodium cacodylate, pH 7.1,
for 30 min at 4uC. After washing three times (10 min each time)
with 0.05 M sodium cacodylate, the cells were dehydrated with a
series of ethanol concentrations (50%, 70%, 85%, 95%, and 36
with 100%) for 30 min for each step at 4uC. Cells were then
infiltrated with ethanol:LR White Resin using ratios of 1:1 (2 h at
4uC), and 1:3 (overnight at 4uC) followed by pure LR White (24 h
at 4uC, with a resin change after 8 h). The cells were then
embedded in gelatin capsules, and resin was polymerized at 4uC
for 48 h under UV light. The blocks were sectioned at the Lisa
Muma Weitz Advanced Microscopy & Cell Imaging Core
Laboratory (University of South Florida) and the sections were
laid on nickel grids. Gold labeling of the nickel grids was carried
out as described previously [28]. Grids were treated with 25 mlo f
TBS-supplemented buffer (0.05 M Tris, 0.85% NaCl, pH 8.3–
8.5, 0.5% normal goat serum, 0.5% normal pig serum and 0.5%
BSA) with 3% nonfat dry milk for 2 h at room temperature.
Grids with thin sections were incubated with 50 ml of anti-MAVS
rabbit antibody (1:100 dilution) diluted in TBS-supplemented
buffer with 3% nonfat dry milk for 3 h at room temperature,
washed and stained with the anti-rabbit antibody conjugated with
15 nm gold (Ted Pella, Inc.) for 1 h at room temperature. The
grids were washed thoroughly and treated with 1:20 dilution of
5 nm gold-Ni-NTA (Molecular Probes) that binds to His6
tags.The grids were washed three times with TBS buffer, and
incubated with 25 ml of 1:100 dilution of goat anti-rabbit
antibody conjugated with 10 nm gold particles (Ted Pella Inc.)
for 1 h at room temperature. After stream washing and three
washes with distilled water (10 min each), the grids were dried
and stained with 2% aqueous uranyl acetate for 5 min and
examined on a JOEL 1200 EX scanning/transmission electron
microscope at 80 kV.
Plasmids
The plasmids used in the study were pNS1-Flag, pFlag vector
control for the mitochondrial fraction isolation, pVAX, pNS1,
pRIG-I (Invivogen) and pMAVS (Invivogen). Cells were trans-
fected with the specified amounts of DNA using Lipofectamine
2000 (Invitrogen). Plasmid pNS1 was constructed by subcloning a
codon-optimized RSVNS1 sequence with restriction enzyme
digestion into the parental pVAX vector. pNS1-Flag was similarly
constructed by restriction enzyme digest into pFlag vector, with
Flag on the amino terminus of NS1. Constructs were verified with
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when probed with an anti-Flag antibody.
Mitochondrial isolation
20610
6 cells were either transfected with pNS1-Flag or pFlag
vector alone, then the mitochondrial fraction was isolated using a
mitochondrial isolation kit (ThermoFisher Scientific). The mito-
chondrial protein was estimated using the BCA protein assay
(ThermoFisher Scientific) and subjected to western blot analysis as
described below.
Immunoprecipitation
30610
6 cells were either transfected with the indicated plasmids
or infected with RSV at the specified MOI. At specified times, the
cells were lysed, and 500 mg aliquots of each protein sample were
incubated with the indicated antibody and immunoprecipitated
using protein A-agarose beads (Invitrogen). Immunoprecipitation
(protocols from eBioScience) was performed using anti-Flag
antibody (Sigma), anti-MAVS antibody (Bethyl Laboratories), or
anti-RIG-I (Cell Signaling) antibodies and the antigen-antibody
complexes were evaluated by western blot analysis.
Western blot analysis of proteins
Aliquots of the mitochondrial proteins (100 mg) or the
immunoprecipitated complexes were boiled for 5 min in 26
protein denaturation buffer (2.3% SDS, 10% glycerol, 5% 2-
mercaptoethanol, 62.5 mMTris-HCl and 0.01% bromophenol
blue, pH 6.8) and were resolved by electrophoresis on 4–20%
SDS-PAGE gels (Bio-Rad Laboratories). Proteins were transferred
for 30 min with Towbin buffer (10 mMTris base, 96 mM glycine
in 10% methanol) to nitrocellulose membranes (Bio-Rad). Blots
were blocked for 30 min at room temperature with 5% nonfat dry
milk and 0.1% Tween-20 in Tris-buffered saline (TBS). Blots were
separately probed with rabbit anti-Flag antibody (Sigma), mouse
anti-MAVS (Santa Cruz), anti-COX-IV (Cell Signaling), anti-
RIG-I antibody (Cell Signaling) or polyclonal rabbit antiserum
against recombinant His6-NS1 [25], and finally, the protein bands
were detected by ECL (ThermoFischer Scientific, SuperSignal
West Pico).
Results
Colocalization of RSV NS1 with mitochondria of infected
cells
In an effort to track the very early events of RSV infection, we
used 4-D live cell imaging (Perkin Elmer UltraVIEWHVoX 3D
Live Cell Imaging System) of A549 cells stained with live
mitochondrial stain CMXRos (red in Figure 1) and infected with
rgRSV at 1 MOI. Figure 1Ashows images at several time points
(0:40, 3:31, 5:21, 6:51, 8:53, and 10:43 h) after infection. The last
two images of the bottom panel showmitochondrial staining
(red)and GFP (green)at 10:43 h p.i. The colocalization of GFP
(green) with mitochondria (red) is shown as yellow (merged). The
Pearson’s and Manders’ overlap coefficients were derived with the
JACoPImageJ tool (http://rsb.info.nih.gov/ij/plugins/track/jacop.
html) and are the average of ten individual cells at 10:43 h
p.i.(Fig. 1B). M1 signifies the correlation of mitochondria overlap-
ping GFP, while M2 indicates the overlap coefficient of GFP to
mitochondria.
To investigate binding of NS1 to mitochondria in living cells, we
used Ni
2+-NTA2-dibromobimane conjugates (Ni
2+-NTA2-BM) as
described previously, which exploits the interaction between
polyhistidine and metal ion NTA compounds [26,29]. The
advantage of the chemical labeling method is that it does not
require fixation or permeabilization of the cells with their potential
for introducing artifacts. The chemical structure of Ni
2+-NTA2-
BM and its interaction with the hexahistidine sequences fused to
NS1 is illustrated in Figure 2A. This dye was used to detect the
His6-tagged NS1 expressed by rA2His6-NS1 in infected HEp-2
cells. rA2, which expresses wild-type NS1, was used as a
control.Merged (or individual channels for detecting the mito-
chondria and Ni
2+-NTA2-BM-bound His6-NS1 are shown in
Figure 2B, with BM in green and mitochondrial probe in red
(Fig. 2B). Differential interference contrast (DIC) was used to
monitor cell morphologyand nuclear staining is shown in blue.
Labeling of NS1 occurred in rA2-His6-NS1-infected cells (top
panel, a–c), but not in cells infected with rA2 encoding wild type
NS1 (bottom panel, d–f) at 10 h p.i. demonstrating that Ni
2+-
NTA2-BM is membrane permeable and specific for the His6 tag.
Figure 1. Live cell imaging of Rg-RSV-infected cells. (A). A549 cells were seeded in 35 mm glass-bottom fluorodishes (Fisher Scientific) and
stained with CMXRos, live mitochondrial labeling kit (Molecular Probes) for 15 min at 37uC, washed and then fresh medium (DMEM with 2% FBS) was
added to the cells. Cells were infected with rgRSV at MOI of 1 and visualized on a Perkin Elmer UltraVIEWHVoX 3D Live Cell Imaging System equipped
with a Nikon T inverted microscope. The cells were maintained at 37uC with 5% CO2 throughout the imaging (16 h post-infection). Images were taken
at 0:40, 3:31, 5:21, 6:52, 8:53, and 10:43 hours post-infection. The last two images in the bottom panel show mitochondrial staining and GFP alone
respectively at 10:43 h p.i. The colocalization of GFP (green) with mitochondria (red) is shown as yellow. (B). The Pearson’s and Manders’ overlap
coefficients are represented as the average of ten individual cells at 10:43 hp.i.
doi:10.1371/journal.pone.0029386.g001
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and several colocalization points are shown as white arrows in the
merged image (Fig. 2B/c).The inset provided in image cshows the
higher magnification of the final merged image (mito-NTA2-BM).
Z-stack images of RSV-infected HEp-2 were collected from four
independent experiments. The Pearson’s and Manders’ overlap
coefficients were derived with the JACoPImageJ tool (http://rsb.
info.nih.gov/ij/plugins/track/jacop.html) and are the average of
ten individual cells (Fig. 2C). M1 signifies the correlation of
mitochondria overlapping His6-NS1, while M2 indicates the
overlap coefficient of His6-NS1 to mitochondria. These results
show that His-NS1 is localizedwith mitochondria in rA2His6-NS1-
infected cells.
Colocalization of RSV NS1 with MAVS by immunogold
electron microscopy
Colocalization of RSV NS1 with MAVS was independently
validated using immunoelectron microscopy.A549 cells were
infected with 0.5 MOI rA2His6-NS1 for 1 h, and cells were
harvested at 12 and 24 h post-infection. Figure 3a shows MAVS
protein in sections of uninfected cells stained with rabbit anti-
MAVS antibody followed by secondary anti-rabbit antibody
conjugated with 15 nm gold (black arrow). Figure 3b shows
His6-NS1 in sections of cells stained with 5 nm gold-Ni-NTA
12 hours after rA2-His6-NS1 infection (red arrow). Figure 3c and
d show cell sections 12 and 24 h post-infection respectively,
stained with anti-MAVS antibody (15 nm gold) followed by Ni-
NTA (5 nm gold) antibodies. These results demonstrate that His6-
NS1 colocalizes with MAVS on mitochondria (M).
RSV NS1 colocalizes with MAVS independent of RSV NS2
during infection
To determine whether RSV NS2 is involved in NS1-MAVS
interaction, A549 cells were infected with rA2 or rA2DNS2
(0.1MOI) and at 12 h post-infection (p.i.), cells were stained with
the mitochondrial stain CMXRos (red), Alexa 488-conjugated
anti-His6-NS1(green), and Alexa 647-conjugated anti-MAVS
antibody (purple)and visualized using the Leica TCS SP2 laser
scanning confocal microscope(Fig. 4A & B).Merged images of
NS1with mitochondria and NS1 with MAVS are shown in
figure 4A. Figure 4B shows the 56 enlarged images ofthe cells
infected with rA2 (top panel) and rA2DNS2 (bottom panel)a t1 2h
p.i.In figure 4B, the areas marked by white circlesclearly
demonstrate that NS1 (green) colocalizes with mitochondria
(red)andmitochondrial MAVS proteins (purple). The bottom panel
shows that NS1 colocalizes with mitochondrial MAVS indepen-
dent of RSV NS2. The total merge of NS1, mitochondria and
MAVS is also shown. The Pearson’s and Manders’ overlap
coefficients derived with the JACoPImageJ tool for mitochondria
and NS1 in the presence of rA2 or rA2DNS2 represent the average
Figure 2. Co-localization of His6-NS1 with mitochondria in infected cells using Ni
2+-NTA2-BM. (A) Structure of Ni
2+-NTA2-BM [26]. (B) rA2-
His6-NS1 or rA2 were used to infect HEp-2 cells at a MOI of 2. At 10h p.i., infected cells were labeled with CMXRos (red), DRAQ5 (blue), and 50 mMNi
2+-
NTA2-BM. Fluorescence was detected using an Olympus FV1000 MPE multiphoton laser scanning microscope. The cells were maintained at 37uC with
5% CO2 throughout the imaging (Z min). Shown are micrographs of rA2-His6-NS1-infected cells collected 10 h p.i (a–c)and rA2 RSV at 10 hp.i. (d–f)
demonstrating site-specificity for Ni
2+-NTA2-BM. Excitation wavelengths of 405, 563 and 633 nm and differential interference contrast (DIC) were used
to collect a series of 0.5 mm Z-stack images for each specimen and experiments were performed in triplicate. Images a and d show the mitochondria
(red), b and e represent His6-NS1 (green) and candf are the merged images of red and green along with the blue nuclear stain DAPI and DIC. (C).
Thresholds for the Z-stack images collected in (B) were acquired using RenyiEntropy AutoThreshold ImageJ plugin (Landini) and Pearson’s and
Mander’s coefficients derived with JACoP plugin (Bolte & Cordelieres). The Mander’s coefficient M2 indicates that ,70% of the His6-NS1 detected
overlaps with CMXRos-stained mitochondria at 10 hrs p.i. in rA2-His6-NS1-infected cells.
doi:10.1371/journal.pone.0029386.g002
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cells) and 4D (rA2DNS2-infected cells). M1 signifies correlation of
MAVS overlapping NS1, while M2 indicates the overlap co-
efficient of NS1 to mitochondria. The positive Pearson’s and
Manders’ overlap coefficients suggest colocalization of NS1 with
MAVS and mitochondria, independent of NS2.
RSV NS1 associates with MAVS in infected cells
HEp-2 cells were mock-infected or infected at an MOI of 1 with
either rA2or rA2 DNS1 orrA2 DNS2 and at 24 h post-infection
(p.i.), total cell lysates were immunoprecipitated with anti-MAVS
antibody and analyzed by western blotting with anti-NS1
antiserum. At 24 h p.i., NS1 was detected in the anti-MAVS
precipitates from lysates of rA2- and rA2 DNS2-infected cells, but
not mock- or rA2 DNS1-infected cells (Fig. 5A). Whole cell lysates
from mock- or rA2-infected cells at 24 h p.i were immunoblotted
using anti RSV-F antibody (ChemiconMAB8262) (Fig. 5B, right-
panel). The specificity of NS1-MAVS interaction is shown when the
same lysates (mock- or rA2- or rA2 DNS1-infected cells) 24 hp.i.
were immunoprecipitated with anti-MAVS antibody and probed
for MAVS and RSV F protein (Fig. 5B, left panel).
NS1 protein binds to MAVS and colocalizes to
mitochondria in transfected cells
A549 cells were transfected with either pNS1-Flag plasmid or
pFlag plasmid. Mitochondrial proteins were separated by SDS-
PAGE and blots were analyzed using rabbit anti-Flag antibody
and anti-COX-IV which acts as a loading control for mitochon-
drial fractions. Figure 6A demonstrates that NS1 is present in the
mitochondria. Immunoprecipitation of total cell extracts of the
transfected cells using anti-MAVS antibody and immunoblotting
for Flag showed that MAVS and Flag-NS1 are associated (Fig. 6B).
Further, A549 cells were transfected with pNS1-Flag, stained for
mitochondria (red, CMXRos), Flag (green), MAVS (purple), and
with a nuclear stain (blue) and visualized using the Leica TCS SP2
laser scanning confocal microscope (Fig. 6C). In Figure 6C, images
a–c showA549 cells 24 h after transfection stained for mitochon-
dria (red, CMXRos), Flag (green, Alexa Fluor 488) and MAVS
(purple, Alexa Fluor 647), respectively. Figure 6C (d and e) shows
the merges between red and green and green and purple
respectively, while panel f is the total merge between red, green,
and purple. The colocalization of mitochondria and NS1-Flag is
shown as yellow (marked by a square, d) and colocalization of
MAVS and NS1-Flag is shown as white (marked by a square, e).
NS1 protein inhibits RIG-I from binding to MAVS in RSV-
infected cells and NS1-transfected cells
A549 cells were infected with rA2 or rA2DNS1 (MOI=1). The
cells were harvested 24 h after infection and whole cell lysates
were western blotted for RIG-I, MAVS and NS1. Results (Fig. 7A,
top panel) show that rA2-infected cells induced higher expression of
RIG-I compared to mock- or rA2DNS1-infected cells. The same
lysates were immunoprecipitated with anti-RIG-I antibody and
the immunocomplexes were western blotted using anti-RIG-I,
anti-MAVS and anti-NS1 antibodies (Fig. 7A, bottom panel). Results
show that at 24 h p.i., immunoprecipitation of RIG-I in rA2-
infected cells pulled down decreased amounts of MAVS as
compared to mock or rA2 DNS1 infections (Fig. 7A). Furthermore,
densitometric quantification (Fig. 7B) of the band intensities of
RIG-I and MAVS of the immunoprecipitation blot (Fig. 7A, bottom
panel) show that the MAVS to RIG-I ratio was significantly
decreased in the presence of NS1.
To further assess the activity of NS1 in inhibiting the interaction
between RIG-I and MAVS, A549 cells were transfected with
pVAX (vec) or pNS1 plasmids (2 mg/million cells) along with
0.2 ng/ml poly (I:C) as an activator of interferon responses
(Fig. 7C). Figure 7C shows that NS1 expression in transfected cells
disrupts the interaction between MAVS and RIG-I. The cells were
harvested at 12 and 24 h after transfection and whole cell lysates
were immunoprecipitated with anti-MAVS and immunoblotted
with anti-RIG-I and anti-MAVS antibodies. At both time points,
co-immunoprecipitation assays showed that transfection of pNS1
inhibits the association of RIG-I and MAVS in contrast to the
vector control (Fig. 7C). Increasing amounts of pNS1 were
cotransfected with constant amounts of pMAVS and pRIG-I,
along with 0.2 ng/ml poly(I:C). Competitive inhibition of
interaction of MAVS with RIG-I was determined by immuno-
precipitation/immunoblotting as described in Figure 7D. Trans-
fection with vector pVAX was used as control and to maintain a
constant amount of transfected DNA. With increasing amounts of
NS1 in the transfected cells, the level of interaction between
MAVS and RIG-I decreases (Fig. 7D).
Discussion
In influenza virus infection, the viral RNA is detected by RIG-I,
which then interacts with MAVS leading to the induction of NF-
kB-responsive genes and type-I IFN production [30,31]. It was
further demonstrated that the influenza virus employs its NS1
protein to subvert the RIG-pathway through MAVS [32,33].
Similarly, the RSV NS2 protein binds to RIG-I, which in turn
Figure 3. Colocalization of NS1 with MAVS by using immuno-
gold electron microscopy. A549 cells were mock-infected or
infected with 0.5 MOI rA2-His6-NS1 for 1 h. Cells were harvested at 12
and 24 h post-infection and processed for immunogoldelectron
microscopy. Thin sections on nickel grids were treated with rabbit
anti-MAVS antibody (1:100 dilution) for 3 h at room temperature,
washed and then stained with 15 nm gold-labeled anti-rabbit
secondary antibody. The grids were washed thoroughly and treated
with a 1:20 dilution of 5 nm gold-Ni-NTA (Molecular Probes) that binds
to His tags. Cells infected with rA2-His6-NS1 were stained for His-NS1
with 5 nm gold (red arrow) and for MAVS protein on mitochondria with
15 nm gold (black arrows). (a) Ultrathin sections of uninfected cells
showing the 15 nm gold staining of MAVS protein (black arrow). (b)
Ultrathin sections of infected cells 12 h p.i. showing His6 protein stained
using 5 nm gold-Ni-NTA. The inset shows His6-NS1 localized on the
mitochondria. (c&d ) Sections of cells 12 and 24 h p.i. showing
colocalization of NS1 with the MAVS protein. Insets (1 & 2) show
colocalization of NS1 (red arrow) and MAVS (black arrow).
doi:10.1371/journal.pone.0029386.g003
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signaling and IFN production.A major finding of this study is that
RSV NS1 protein associates with mitochondria, specifically with
the MAVS protein. This binding of NS1 interferes with RIG-I-
MAVS interaction, which is important for the production of IFN-
b, without significantly affecting expression of either RIG-I or
MAVS. In this report, we have substantiated this statement with
three lines of evidence.
First, we have shown by live-cell imaging that in cells infected
with rgRSV, the green fluorescent protein, which is among the
first to be translated,is found in the vicinity of mitochondria that
exist in the nuclear periphery. This is consistent with previous
reports of localization of polio virus in perinuclear membrane
complexes in Hela cells [34]. Second, wevisualized the localization
of His6-NS1 in liveRSV-infected epithelial cells using a nickel-
conjugated fluorophore and confocal microscopy.While such an
approach has been used in vitro, itsin vivo use in live infected cells
is innovative. Our data show that NS1 localizes to the cytoplasm
near mitochondria.
In addition to our studies using the chemical labeling method
for visualizing hexahistidine-tagged proteins, standard electron
microscopy, and immunofluorescence wereused to determine the
location of NS1 in RSV-infected cells. With the advancement of
electron and confocal microscopy, subcellular localization can be
observed under stable conditions in fixed or living mammalian
cells; however, chemical fixation has the potential to cause
artifacts. We demonstrated the application of three different
Figure 4. Co-localization of NS1 with MAVS in mitochondria during RSV infection. A549 cells were infected with rA2 or rA2DNS2 (0.1
MOI).Twelve hours after infection, cells were stained with the mitochondrial stain CMXRos (red). Cells were then fixed and stained with Alexa 488-
conjugated anti-NS1 antibody (green) and Alexa 647-conjugated anti-MAVS antibody (purple). Stained cells were viewed under the Leica TCS SP2
laser scanning confocal microscope (A) Images (4006magnification) show individual staining colors, and merged images of NS1-mitochondria and
NS1-MAVS are also shown. (B) The images are a 56enlargement of a 4006image. The top panel shows the cells infected with rA2 and the bottom
panel the cells infected with rA2DNS2. The areas marked by white circles show the presence of NS1 in mitochondria and colocalization with MAVS.
The first pair of images are merges of NS1 and mitochondria. The second pair show NS1 merged with MAVS and the last pair shows all three. (C).
Correlation analysis of the co-localization of NS1 with mitochondria in rA2 infected cells. (D). Correlation analysis of the colocalization of NS1 with
mitochondria in rA2DNS2 infected cells.Pearson’s coefficient for MAVS and NS1 is shown along with Manders’ coefficients (M1 & M2), which represent
the fraction of the mitochondrial red overlapping with NS1 green and the fraction of NS1 green overlapping with the mitochondrial red, respectively.
doi:10.1371/journal.pone.0029386.g004
Figure 5. MAVS co-immunoprecipitates with NS1 in epithelial
cells infected with rA2- RSV or rA2. (A)H E p - 2c e l l sw e r e
eithermock-infectedor infected with rA2 or rA2DNS1or rA2DNS2 at an
MOI of 1. At 24 h p.i., total cell extracts were immunoprecipitated with
anti-MAVS followed by western blot analysis using anti-NS1 or anti-
MAVS antibodies. (B) Whole cell lysates from mock or rA2 infected HEp-
2 cells were immunoblotted for RSV F protein using anti RSV F antibody
(Chemicon MAB8262) (right panel). The lysates from mock or rA2 or
rA2DNS1 were co-immunoprecipitated with anti-MAVS antibody and
probed for MAVS and RSV F protein (left panel).
doi:10.1371/journal.pone.0029386.g005
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the mitochondria in NS1-transfected and RSV-infected epithelial
cells. The standard method of immunofluorescence is frequently
used in colocalization studies and to avoid nonspecific binding and
the need for potentially cross-reactive secondary antibodies, we
used Zenon labeling kits. We first observed colocalization of NS1
at 16 hp.i. on CMXRos red-stained mitochondria, then we
showed that NS1 colocalized with mitochondria at 10 h p.i. using
a novel chemical labeling approach. We confirmed the specificity
of the polyclonal anti-NS1 antibody in immunofluorescence by
performing TEM analysis using Ni
2+-NTA-nanogold. In addition,
we showed co-immunoprecipitation of NS1 with MAVS, an
Figure 6. RSV NS1 is present on the mitochondria and co-immunoprecipitates with MAVS in NS1-transfected cells. (A). A549 cells
were transfected with pNS1-Flag (NS1) or pFlag (Vec). Mitochondria were isolated and the proteins were analyzed by western blot for Flag and Cox-IV
(B). Total cell extracts were immunoprecipitated with anti-MAVS antibody and analyzed by western blotting with anti-Flag and anti-MAVS antibodies.
(C). A549 cells transfected with pNS1-Flag were stained for Flag (green, a), mitochondria (CMXRos, red, b), and MAVS (purple, c) and visualized using
the Leica TCS SP2 laser scanning confocal microscope. The squares indand e show co-localization of NS1 with mitochondria and MAVS respectively,
and the box in f shows co-localization of NS1, MAVS and mitochondria. The insets in d,e, and f show the enlargement of the indicated areas.
doi:10.1371/journal.pone.0029386.g006
Figure 7. NS1 protein prevents RIG-I from binding to MAVS. (A) A549 cells were mock-infected or infected with rA2 or rA2DNS1 (MOI=1).
Whole-cell lysates were subjected to western blot analysis with anti-RIG-I, anti-MAVS, and anti-NS1antibodies (top panel). The same lysates were
immunoprecipitated with anti-RIG-I antibody and the protein complexes were immunoblotted with the indicated antibodies (bottom panel). (B)The
bar graph represents the densitometric quantification of the band intensities as the ratio of MAVS to RIG-I. (C) A549 cells were transfected with the
indicated plasmids (12 mg of either pVAX or pNS1) and incubated with 0.2 ng/ml poly (I:C). Cytoplasmic extracts from cells 12 and 24 h after
transfection were immunoprecipitated with anti-MAVS and immunoblotted with anti-RIG-I antibody. (D) Increasing amounts of pNS1 were co-
transfected with constant amounts (6 mg) of pMAVS and pRIG-I, along with 0.2 ng/ml poly (I:C). Competitive inhibition of the interaction of MAVS
with RIG-I was tested using IP, as described in (C). Transfection with pVAX was used to keep the total amount of transfected DNA constant.
doi:10.1371/journal.pone.0029386.g007
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cells.
Confocal and immuno-electron microscopy showed co-locali-
zation of NS1 and MAVS on mitochondria of RSV-infected cells
and NS1-transfected cells. The lack of any difference in this regard
between cells infected with rA2 or NS2-deficient RSV showed that
NS1 binding to MAVS is not affected by NS2. To demonstrate
direct interaction between NS1 and MAVS, we immunoprecip-
itated whole cell lysates from either mock- orrA2- or NS1- or NS2-
deficient RSV-infected cells with anti-MAVS antibody, and NS1
was found to co-IP with MAVS in both rA2- and NS2-deficient
RSV. Also, no other protein (RSV F) was found to interact with
MAVS, showing the specificity of interaction between MAVS and
NS1. At the same time in NS1-transfected cells, mitochondrial
fractions showed the presence of NS1 that co-IP’d with MAVS.
We further investigated the interaction between RIG-I and
MAVS in the presence of NS1. When whole cell lysates were
immunoblotted, RIG-I expression was found to begreater in rA2-
infected cellsthan in mock- or rA2DNS1-infected cells,which is
consistent with previous findings [35]. When the same lysates were
immunoprecipitated with anti-RIG-I antibody, MAVS and the
NS1 complex were pulled down along with RIG-I. Our results
demonstrate that infection of cells with rA2 DNS1 does not appear
to affect the interaction of RIG-I with MAVS, in contrast to
infection by rA2, suggesting that NS1 interference with the
interaction between RIG-I and MAVS may be an important
factor in RSV infection. The degree of inhibition of the antiviral
response is dependent on NS1 dose. The dose-dependent
regulation of RIG-I/MAVS interaction is clearly demonstrated
in NS1-transfected cells. Unlike RSV NS2, which was previously
observed to bind to RIG-I for inhibition of IFN-b, NS1disrupts the
RIG-I/MAVS signaling through binding of MAVS, which could
lead todiminished antiviral responses as our lab has previously
reported [12,23]. In contrast to Swedan et al., we utilized
immunoprecipitation enrichment to observe changes in abun-
dance of the RIG-I/MAVS complex and were not measuring total
protein or RNA expression [36].While the precise mechanism of
RSV NS1 inhibition of RIG-I/MAVS interaction remains
unknown, clearly this differs from the hepatitis C virus (HCV)
NS3-4A, a serine protease of HCV known to attenuate IFN-b
production by cleaving MAVS [37].
Collectively, our evidence supports the hypothesis that RSV
NS1 interferes with the antiviral signaling pathway by binding to
the mitochondrial protein MAVS during early infection and
disrupting the MAVS/RIG-I interaction that is necessary for
signaling. To our knowledge, this is the first report that
demonstrates the mitochondrial localization of NS1and our data
support a critical role for NS1 in the initial stage of infection with
RSV. Taken together, these data demonstrate that RSV targets
the mitochondria in cells by producing a nonstructural NS1
protein that binds to MAVS and negatively regulates the RIG-I-
mediated antiviral host defense responses such as type-I IFN
production. The binding of NS1 to MAVS most likelyresults in
steric hindrance that prevents RIG-I/MAVS interaction, but the
detailed molecular mechanism of this inhibition of RIG-I and
MAVS leading to interference with IFN-b production remains to
be established.
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